Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia.

NCT: NCT05842239 · RECRUITING

NCT IDNCT05842239
StatusRECRUITING
Start Date2024-01-20
Completion2030-12-01

Brief Summary

Infertility in a couple is defined as the inability to achieve conception despite one year of frequent, unprotected intercourse. Infertility affects approximately 12% of couples attempting to conceive. The goal of this study is to explore the potential beneficial effect of HBOT on sperm count of infertile male due to oligospermia.

Frequently Asked Questions

What is Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia.?

Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia. is a clinical trial registered under NCT05842239. Current status: RECRUITING.

What is the status of NCT05842239?

The current status of NCT05842239 (Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia.) is: RECRUITING.

When did Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia. start?

Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia. started on 2024-01-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑